LDN for Parkinson's Disease

LDN for Parkinson's Disease
Author: Robert Rodgers, PhD
Publisher: Parkinsons Recovery
Total Pages: 29
Release: 2014-02-10
Genre: Health & Fitness
ISBN:

LDN (Low Dose Naltrexone) is a proven-safe (by the FDA in 50mg doses!) off-label prescription drug which has gained a great deal of attention over the past few months due to its remarkable disease modifying effects of controlling and reversing symptoms of Parkinson's Disease. Lexie is one person who has experienced a reversal of most of her Parkinsons Disease symptoms over the past 5 years. She was officially diagnosed with Parkinsons disease in 2008 (although her non-motor symptoms began 20 years earlier). In this question and answer format with Robert Rodgers, PhD from Parkinsons Recovery, Lexie offers detailed information about her experience with taking LDN. She has been able to titrate off her daily use of traditional PD medications, while controlling and reversing most of her own PD symptoms, thanks to LDN. Many doctors are not familiar with LDN as a treatment for Parkinson's symptoms. It is a prescription medication, so a prescription from a doctor is necessary. Lexie offers suggestions about how to discuss a request for a LDN prescription from your doctor and offers specific suggestions about where to get LDN once a prescription is in hand. This interview was originally published in Pioneers of Recovery, a series of stories by people who succeeded in reversing their Parkinson's symptoms using one modality or another. Lexie's story of recovery centers on the use of LDN which has been so beneficial to her own recovery from Parkinsons Disease.

The LDN Book, Volume Two

The LDN Book, Volume Two
Author: Linda Elsegood
Publisher: Chelsea Green Publishing
Total Pages: 289
Release: 2020-10-09
Genre: Health & Fitness
ISBN: 1603589910

A comprehensive examination of Low Dose Naltrexone—a little-known drug with big potential "[LDN] raises hopes of reversing memory loss in old age."—the Guardian A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. LDN, originally prescribed in higher doses as a treatment for opioid addiction, works by blocking opioid receptors, thereby stimulating the production of endorphins, mitigating the inflammatory process, and stabilizing the immune response. Prescribed off-label and administered in small daily doses, this generic drug has proven useful in treating many different ailments. Expanding on the information presented in The LDN Book, Volume 1, which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue, Volume 2 highlights the latest clinical trials, case studies, and research with explanations from a dozen medical professionals on how they are using LDN to help patients suffering from: Chronic pain Parkinson’s disease Dermatologic conditions Traumatic brain injury Lyme disease and more The LDN Book, Volume 2 is both a resource for practitioners, pharmacists, and patients, and a renewed call for further research on the healing potential of this generic drug.

The Promise of Low Dose Naltrexone Therapy

The Promise of Low Dose Naltrexone Therapy
Author: Elaine A. Moore
Publisher: McFarland
Total Pages: 224
Release: 2009-01-22
Genre: Health & Fitness
ISBN: 0786452587

Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.

Road to Recovery from Parkinsons Disease

Road to Recovery from Parkinsons Disease
Author: Robert Rodgers, PhD
Publisher: Parkinsons Recovery
Total Pages: 368
Release: 2013-09-03
Genre: Health & Fitness
ISBN:

Do you have Parkinson's Disease? Are you looking for ways to feel better? Road to Recovery from Parkinson's Disease gives a comprehensive overview of the factors that cause the symptoms of Parkinson's and covers all the natural treatments that are helping thousands of people with Parkinsons become healthy and well. There is no doubt about it. Many medical specialties provide relief from the symptoms of Parkinson's Disease. Road to Recovery from Parkinson's Disease reveals the natural therapies and safe treatments that persons with Parkinson's have discovered help them steer a steady course on the road to recovery.

Pain Management and the Opioid Epidemic

Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Total Pages: 483
Release: 2017-09-28
Genre: Medical
ISBN: 0309459575

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Pioneers of Recovery

Pioneers of Recovery
Author: Robert Rodgers, PhD
Publisher: Parkinsons Recovery
Total Pages: 245
Release: 2011-10-21
Genre: Science
ISBN: 0981976735

Parkinsons Recovery Radio show guests often talk about how they reversed the symptoms of Parkinsons Disease and restored the delicate balance of hormones in their body. Now you can read nine of these amazing stories as they were first told on the radio show in this 2012 release of Pioneers of Recovery. Each chapter includes details on the steps that each pioneer took to make miracle of healing happen. Therapies that paved the road to recovery include: TMJ adjustments, Candida cleanses, Voice Profiling,sound therapy,Tai Chi, Martial Arts, Qigong, Low Dose Naltrexone, forced exercise, Chinese medicine, supplements, diet, detoxes and even opening blocked jugular veins. Pioneers of Recovery will transform your expectation about the possibility of recovery. You will be intrigued by how each pioneer went about reversing their symptoms. These stories confirm the wisdom of the ages that the body does know how to heal. It just needs a little help remembering how.

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder
Author: American Psychiatric Association
Publisher: American Psychiatric Pub
Total Pages: 226
Release: 2018-01-11
Genre: Medical
ISBN: 0890426821

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.

The Cure for Alcoholism

The Cure for Alcoholism
Author: Roy Eskapa
Publisher: BenBella Books
Total Pages: 369
Release: 2012-10-23
Genre: Psychology
ISBN: 1937856135

Finally, there is a cure for alcoholism. This is the first step. Featuring new and updated information and studies, including an introduction by actress Claudia Christian, the second edition of The Cure for Alcoholism delivers exactly what millions of alcoholics and families of alcoholics have been hoping for: a painless, dignified, and medically proven cure for their addiction. Backed by 82 clinical trials and research that extends back to 1964, The Sinclair Method deploys an opiate-blocking medication in a very specific way—in combination with ongoing drinking—to extinguish the addictive "software" in the brain. The de-addiction process rolls back the addictive mechanism in the brain to its original pre-addicted state—before the first drink was consumed, making this program an actual cure for alcoholism. Drs. Roy Eskapa and David Sinclair of The Sinclair Method have put together a sound scientific book that proves that with this particular method, alcoholism can be cured in more than 78 percent of patients. What's more, the treatment avoids the dangerous withdrawal symptoms, allowing patients to detox gradually and safely while they are still drinking. This removes the need for expensive and unpleasant inpatient rehabilitation programs. Actual drinking levels and cravings automatically decrease until control over alcohol is restored. The bottom line is that patients can control their drinking or stop altogether with the simple yet powerful process outlined in The Cure for Alcoholism. Including a new introduction by actress Claudia Christian about The Sinclair Method's impact on her life, updated trial information, and a letter explaining the treatment that can be given to doctors by patients, The Cure for Alcoholism is a revolutionary book for anyone who wants to gain control over drinking.

The LDN Book

The LDN Book
Author: Linda Elsegood
Publisher: Chelsea Green Publishing
Total Pages: 242
Release: 2016-02-15
Genre: Medical
ISBN: 1603586652

Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more? “[LDN] raises hopes of reversing memory loss in old age.”—the Guardian Over 30,000 copies sold! Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? The LDN Book explains: The drug’s origins Its primary mechanism The latest research from practicing physicians and pharmacists Compiled by Linda Elsegood of The LDN Research Trust—the world’s largest LDN charity organization with over 19,000 members worldwide—the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices. The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.

Insights Into Lyme Disease Treatment

Insights Into Lyme Disease Treatment
Author: Connie Strasheim
Publisher: BioMed Publishing Group
Total Pages: 446
Release: 2009
Genre: Medical
ISBN: 0982513801

Health care journalist Connie Strasheim has conducted intensive interviews with thirteen of the world's most competent Lyme disease healers, asking them thoughtful, important questions, and then spent months compiling their information into organized, user-friendly chapters that contain the core principles upon which they base their medical treatment of chronic Lyme disease. --publisher.